# ORIG3N

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/orig3n

- Industry: Biotechnology
- Headquarters: Boston, US
- Website: www.orig3n.com
- Total disclosed funding: $28M
- Latest round: Series B (Jul 11, 2018)
- Investors on record: 13

## About

ORIG3N, Inc. is a biotechnology company based in Boston, US that leverages genetic information to enhance healthcare solutions, focusing on personalized medicine and consumer genetics.Founded in 2014 in Boston, US, ORIG3N, Inc. specializes in providing genetic information and insights to consumers. In July 2018, the company raised USD 14.4 mn in Series B funding led by Haitong International Securities Group, alongside various returning investors. Robin S serves as CEO, bringing significant leadership experience to the company.ORIG3N, Inc. offers a suite of innovative services centered on genetic testing and personal health insights. Their product line includes genetic tests that empower individuals to understand their health risks and optimize their well-being. The company serves a broad customer base including health-conscious consumers and medical professionals, with services marketed primarily in North America, Europe, and Asia.ORIG3N, Inc. operates on a revenue model that combines subscription services with fees from genetic testing. Clients typically engage through direct purchases and subscription plans, which establish predictable revenue streams. Additionally, strategic partnerships with healthcare providers and retailers enhance their sales channels, contributing to both B2B and direct-to-consumer revenue generation.Following the Series B funding round completed in July 2018, ORIG3N, Inc. plans to utilize the USD 14.4 mn raised to expand its product offerings and enhance its genetic testing capabilities. The company aims to roll out new testing solutions targeting personalized health insights by the end of 2020, while also exploring entry into new international markets in Asia and Europe within the next two years.

## Funding rounds

- Series B, Jul 11, 2018, $14M — Alexandria Venture Investments, Hatteras Venture Partners, DEFTA Partners, 180 Degree Capital, Laboratory Corporation of America Holdings, WOORI Venture Partners, Mountain Group Partners, Vectr Ventures, Haitong International Securities Group, Spectrum Health Ventures, MMIC Investment Holdings Inc.
- Series A, Dec 16, 2015, $13M — Hatteras Venture Partners, DEFTA Partners, 180 Degree Capital, Laboratory Corporation of America Holdings, WOORI Venture Partners, Mountain Group Partners, Syno Capital
- Series A, Feb 5, 2015, $1.5M — Hatteras Venture Partners, 180 Degree Capital, WOORI Venture Partners, Mountain Group Partners, Harris & Harris, Ltd.

## Investors

- Hatteras Venture Partners (https://capitalatlas.ai/funds/hatteras-venture-partners) — Series A, Series B
- 180 Degree Capital (https://capitalatlas.ai/funds/180-degree-capital) — Series A, Series B
- WOORI Venture Partners (https://capitalatlas.ai/funds/woori-venture-partners) — Series A, Series B
- Mountain Group Partners (https://capitalatlas.ai/funds/mountain-group-partners) — Series A, Series B
- Harris & Harris, Ltd. — Series A
- DEFTA Partners (https://capitalatlas.ai/funds/defta-partners) — Series A, Series B
- Laboratory Corporation of America Holdings — Series A, Series B
- Syno Capital (https://capitalatlas.ai/funds/syno-capital) — Series A
- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series B
- Vectr Ventures (https://capitalatlas.ai/funds/vectr-ventures) — Series B
- Haitong International Securities Group — Series B
- Spectrum Health Ventures (https://capitalatlas.ai/funds/spectrum-health-ventures) — Series B
- MMIC Investment Holdings Inc. — Series B